Novel transdermal curcumin therapeutic preserves endothelial barrier function in a high-dose LPS rat model

AbstractSepsis is a devastating complication of infection and injury that, through widespread endothelial dysfunction, can cause perfusion deficits and multi-organ failure. To address the recognised need for therapeutics targetting the endothelial barrier, a topical formulation (CUR; VASCEPTOR™; Vas...

詳細記述

書誌詳細
出版年:Artificial Cells, Nanomedicine, and Biotechnology
主要な著者: William H. Nugent, Danuel A. Carr, Joel Friedman, Bjorn K. Song
フォーマット: 論文
言語:英語
出版事項: Taylor & Francis Group 2023-12-01
主題:
オンライン・アクセス:https://www.tandfonline.com/doi/10.1080/21691401.2022.2164584